Wednesday, October 2, 2013 Tuesday, October 1, 2013- Final Glance: Pharmaceuticals companiesAP (Tue, Oct 1)
- Apple Now Holds 10% of All Corporate Cash: Moody'sat The Wall Street Journal (Tue, Oct 1)
- Can you make money on Obamacare?Talking Numbers (Tue, Oct 1)
- Does Lexicon Own the Future of Type 2 Diabetes?at Motley Fool (Tue, Oct 1)
- Top-line Data on Astellas' IsavuconazoleZacks (Tue, Oct 1)
- Merck’s Big Bet on R&D Founders, and 8,500 Job Cuts Ensueat BusinessWeek (Tue, Oct 1)
- No Shutdown for the Markets as the Dow Runs Higherat Motley Fool (Tue, Oct 1)
- Merck rises after announcing major restructuringat theflyonthewall.com (Tue, Oct 1)
- Earnings Outliers: The Real Deal on Corporate Profitabilityat BusinessWeek (Tue, Oct 1)
- Merck to slash annual costs by $2.5 billion, cut 8,500 jobsReuters (Tue, Oct 1)
- Merck to slash annual costs by $2.5 bln, cut 8,500 jobsReuters (Tue, Oct 1)
- Candy Crush IPO Needs a Better Innovation Planat BusinessWeek (Tue, Oct 1)
- Midday Glance: Pharmaceuticals companiesAP (Tue, Oct 1)
- Merck Restructuring Plan To Save $2.5 Bil Lifts Stockat Investor's Business Daily (Tue, Oct 1)
- Merck Cuts 8,500 Jobs, Amazon Hires 70,000 For Holiday Season As BLS Suspends Jobs Reportat Forbes (Tue, Oct 1)
- Tech Cash Hoard Grows as Activists Press Apple Payoutsat TheStreet (Tue, Oct 1)
- Netflix Rides Hiked Price Target, Pfizer Drug Hits a Snag, and 3 More Hot Stocksat Wall St. Cheat Sheet (Tue, Oct 1)
- Pfizer Invites Public To View And Listen To Webcast Of October 29 Conference Call With AnalystsBusiness Wire (Tue, Oct 1)
- Early Glance: Pharmaceuticals companiesAP (Tue, Oct 1)
Add PFE News to My Yahoo!   | |
|
0.41%